GeneMachines Sells OmniGrid Microarrayers to Singapore Genome Institute

Jul 25, 2001

NEW YORK, July 25 – GeneMachines has sold two OmniGrid microarrayers to the Genome Institute of Singapore, the company said Wednesday.

The Genome Institute will use the microarrayers in its work on zebrafish and mouse model systems, as well as cancer genomics and other research that comprises part of Singapore’s promised $4 billion investment in genomics and biotechnology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Silencing for Preeclampsia

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

Settlement Expected in Duke Case

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

Something Different

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.

This Week in PNAS

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

Main menu